Soluble wild-type ACE2 molecules inhibit newer SARS-CoV-2 variants and are a potential antiviral strategy to mitigate disease severity in COVID-19
| Image |  |
|---|---|
| Description | |
| Author/s | |
| Publication date | August 11, 2023 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Access work |
https://academic.oup.com/cei/advance-article-pdf/doi/10.1093/cei/uxad096/53851369/uxad096.pdf |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |